“This is Part 2 of my interview with ALS and stem cell advocate, Ted Harada. You can read Part 1 on where things stand today with ALS, the FDA, and the Ice Bucket Challenge. What’s your opinion of t...”
“BrainStorm shares to be listed on Nasdaq Capital Market Reuters TEL AVIV (Reuters) - BrainStorm Cell Therapeutics Inc., an Israeli developer of adult stem cell treatments for neurodegenerative diseases, said its stock has been approved for listing...”
“No one is suggesting that this process take the place of the existing clinical trial process. And no company (though I can only speak for Neuralstem) will offer a drug if the FDA tells it not to. The heart of the RTT bill recognizes ...”
“Team Gleason Announces Collaborative Initiative: Answer ALS NewOrleansSaints.com With our focus on collaboration, we will utilize the proven model of the Robert Packard Center for ALS Research to create an entirely new and expansive ALS...”
“BrainStorm Announces Publication of Preclinical Multidose Study of NurOwn SYS-CON Media (press release) This paper describes the safety of single and repeated intramuscular administration of NurOwn, the Company's proprietary mesenchymal stem cells...”
“FDA Grants Fast Track Designation to NurOwn™ for the Treatment of ALS MarketWatch NurOwn™ consists of autologous mesenchymal stem cells that have been induced to secrete neurotrophic factors, and is currently being studied in a randomized,...”
“Ted Harada is a wonderful patient advocate for the stem cell field and for the development of safe and effective stem cell products to treat ALS. Ted has ALS and received stem cell-based treatments...”
“Ice Buckets and IPOs: 6 biotechs targeting CNS diseases NASDAQ Amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease) is a fatal neurodegenerative disease that affects about 30,000 people in the US.”
“Revolutionary stem-cell ALS treatment begins advanced trials Canada Free Press As the Ice Bucket Challenge raises millions for research into amyotrophic lateral sclerosis (ALS), an Israeli treatment to ease symptoms and slow the progression of ALS...”
“Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data NEWS.GNOM.ES Neuralstem's NSI-566 spinal cord-derived neural stem cell therapy Phase II clinical trials for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's...”
“News 92 FM Beyond The Ice Bucket: Excitement Builds Over US Trials Of New ALS Treatment News 92 FM The treatment harvests a patient's stem cells from their bone marrow, treats the cells with chemicals until they grow new neurons, then injects them...”
“News from Rutgers Lou Gehrig's Sad Farewell and the Disease that Bears His Name News from Rutgers On the Fourth of July 75 years ago, in 1939, legendary first baseman Lou Gehrig – afflicted with a nerve disorder called amyotrophic lateral...”
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.